Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 61-69

  Dalod, Marc ^a   Harzic, Martine ^c   Pellegrin, Isabelle ^c   Dumon, Béatrice ^c   Hoen, Bruno ^c   Sereni, Daniel ^c   Deschemin, Jean Christophe ^c   Levy, Jean Paul ^c   Venet, Alain ^c   Gomard, Elisabeth ^b  

^a Hôpital Cochin ^*  (France)

^b INSERM   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG COMBINATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 17344370286     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515587     Document Type: Article

References (20)

1. Pedersen C, Linhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. Br Med J 1989;299:154-7.
2. Sinicco A, Fora R, Sciandra M, Lucchini A, Caramello P, Gioannini P. Risk of developing AIDS after primary acute HIV-1 infection. 1 Acquir Immune Defic Syndr 1993;6:575-81.
3. Henrard D, Daar E, Farzadegan H, et al. Virologie and immunologic characterization of symptomatic and asymptomatic primary infection. J Acquir Immune Defic Syndr 1995;9:305-10.
4. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitaten of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-9.
5. Pantaleo G, Demarest JF, Schacker T, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci USA 1997;94:254-8.
6. Safrit J, Koup R. The immunology of primary HIV infection: which immune response control HIV replication? Curr Opin Immunol 1995;7: 456-61.
7. Pellegrin I, Legrand E, Neau D, et al. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr 1996;11:438-47.
8. Moog C, Fleury HJA, Pellegrin I, Kim A, Aubertin AM. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type-1-infected individuals. J Virol 1997;71:3734-41.
9. Connick E, Marr D, Zhang XQ, et al. HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res Hum Retroviruses 1996;12:1129-40.
10. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Different patterns of HIV-1-specific cytotoxic T lymphocyte activity after primary infection. AIDS 1995;9:421-6.
11. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-5.
12. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J virol 1994;68:6103-10.
13. Legrand E, Pellegrin I, Neau D, et al. Course of specific T-lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV-1 infected patients. AIDS Res Hum Retroviruses 1997;13:1383-94.
14. Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8-T-cell anti-HIV responses in primary HIV-1 infection. Lancet 1994;344:1671-3.
15. Price DA, Goulder PJR, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary HIV-1 infection. Proc Natl Acad Sci USA 1997;94:1890-5.
16. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997; 3:205-11.
17. Wolinsky SM, Korber BTM, Neumann AU, et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-42.
18. Liu SL, Schacker T, Musey L, et al. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J Virol 1997;71:4284-95.
19. + T cells with a predominant V-beta usage during the primary immune response to HIV. Nature 1994;370:463-7.
20. + anti-HIV lymphocytes in the control of HIV infection. In: Giraldo G, Bolognesi D, Salvatore M, Beth-Giraldo E, eds. Development and applications of vaccines and gene therapy in AIDS. Vol 48. Basel: S Karger, 1996.